Plus, more news about Circle Pharma, Emergent, Cytokinetics, Nxera Pharma, Neurocrine Biosciences, Simcere Zaiming, TargetRx and Calliditas:
Denali Therapeutics to seek accelerated approval in 2025 …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SAN DIEGO — Multiple myeloma patients in the clinic appear to benefit far less from standard treatments when compared with how the same regimens performed
Dive Brief: Boston Scientific has set bullish growth targets for 2024 to 2026, according to analysts. The company is forecasting that a “dramatic shift” to
WASHINGTON — Doctors will get a 1.68% pay hike in Medicare starting March 9 under a deal struck over the weekend to fund part of